Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Timolol for Secondary Intention Wound Healing
NCT07384767Phase 2Not yet recruiting
- Sponsor
- University of California, Davis
- Start
- Oct 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of timolol maleate gel + placebo in surgical wound, sponsored by University of California, Davis. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
timolol maleate gel + placebo
03
Conditions
surgical wound
Beyond the preview
Go deeper on NCT07384767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07384767.